iBio, Inc. (NYSE:IBIO)

Health Care/Life Sciences • Biotechnology

CIK 1420720

Company

iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. It operates through the Biopharmaceuticals and Bioprocessing segments. The Biopharmaceuticals segment involves molecule discovery, development, and licensing activities. The Bioprocessing segment includes contract development and manufacturing services for recombinant proteins. The company was founded on April 17, 2008 and is headquartered in Bryan, TX.

Address
8800 HSC Parkway
Bryan, Texas 77807

Employees
26

Stock Info

Close
$1.22

Day Range
1.18 - 1.25

52 Week Range
1.02 - 52.00

Average volume
205.33K

Short Interest
13.99K (02/15/24)

% of Float Shorted
0.41%

Market Cap
$4.36M

Revenue
N/A

Net Income
-$29.31M

2020 Sales Growth
N/A

Rev. per Employee
$1,923.08

P/E Ratio
N/A

EPS
-$26.22

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

Chairman
William D Clark MBA

Independent Director
Evert B Schimmelpennink

Independent Director
James Thomas Hill

Independent Director
Linda M Armstrong MD

Independent Director
Alexandra Kropotova MD, MBA

Independent Director
Gary L Sender MBA

SEC filings

Date	Form	Event
9 Dec, 2024	4
9 Dec, 2024	3
25 Nov, 2024	4
25 Nov, 2024	4
25 Nov, 2024	4
25 Nov, 2024	4
25 Nov, 2024	4
25 Nov, 2024	3
25 Nov, 2024	8-K
14 Nov, 2024	SC 13G
14 Nov, 2024	SC 13G/A
12 Nov, 2024	10-Q
12 Nov, 2024	8-K
23 Oct, 2024	8-K
10 Oct, 2024	DEF 14A
10 Oct, 2024	ARS
24 Sep, 2024	10-K/A
20 Sep, 2024	10-K
20 Sep, 2024	8-K
14 Aug, 2024	3
6 Aug, 2024	424B5
6 Aug, 2024	EFFECT
2 Aug, 2024	CORRESP
26 Jul, 2024	8-K
25 Jul, 2024	S-3/A
25 Jul, 2024	CORRESP
18 Jul, 2024	UPLOAD
9 Jul, 2024	8-K
3 Jul, 2024	8-K
3 Jul, 2024	S-3
5 Jun, 2024	8-K
3 Jun, 2024	8-K
20 May, 2024	8-K
13 May, 2024	10-Q
13 May, 2024	4
13 May, 2024	4
13 May, 2024	8-K
26 Apr, 2024	4
25 Apr, 2024	424B3
24 Apr, 2024	EFFECT
22 Apr, 2024	UPLOAD
22 Apr, 2024	CORRESP
16 Apr, 2024	S-3
9 Apr, 2024	SC 13G/A
8 Apr, 2024	SC 13G
5 Apr, 2024	SC 13G
4 Apr, 2024	D
1 Apr, 2024	SC 13G
1 Apr, 2024	8-K
26 Feb, 2024	8-K
21 Feb, 2024	8-K
13 Feb, 2024	SC 13G/A
9 Feb, 2024	10-Q
10 Jan, 2024	S-8
8 Jan, 2024	8-K
4 Jan, 2024	SC 13G
26 Dec, 2023	8-K
8 Dec, 2023	8-K
6 Dec, 2023	8-K
6 Dec, 2023	424B3
4 Dec, 2023	EFFECT
30 Nov, 2023	CORRESP
30 Nov, 2023	S-1/A
28 Nov, 2023	8-K
14 Nov, 2023	10-Q
3 Nov, 2023	UPLOAD
3 Nov, 2023	4
27 Oct, 2023	S-1
26 Oct, 2023	DEF 14A
26 Oct, 2023	ARS
16 Oct, 2023	PRE 14A
10 Oct, 2023	8-K
5 Oct, 2023	4
4 Oct, 2023	EFFECT
3 Oct, 2023	4
2 Oct, 2023	8-K
29 Sep, 2023	POS AM
27 Sep, 2023	8-K
27 Sep, 2023	10-K
21 Sep, 2023	8-K
30 Aug, 2023	4
24 Aug, 2023	4
24 Aug, 2023	4
15 Aug, 2023	D
14 Aug, 2023	424B3
11 Aug, 2023	EFFECT
10 Aug, 2023	CORRESP
9 Aug, 2023	UPLOAD
7 Aug, 2023	S-1
7 Aug, 2023	8-K
7 Aug, 2023	424B5
4 Aug, 2023	8-K
28 Jul, 2023	4
13 Jul, 2023	4
10 Jul, 2023	8-K
27 Jun, 2023	8-K	CEO Change
27 Jun, 2023	4
22 Jun, 2023	4
24 May, 2023	4
19 May, 2023	10-Q/A
15 May, 2023	10-Q
24 Apr, 2023	4
24 Apr, 2023	8-K
3 Apr, 2023	4
3 Apr, 2023	8-K
3 Apr, 2023	4
30 Mar, 2023	8-K
28 Mar, 2023	4
13 Mar, 2023	8-K
23 Feb, 2023	4
22 Feb, 2023	424B3
21 Feb, 2023	8-K
16 Feb, 2023	8-K
14 Feb, 2023	10-Q
14 Feb, 2023	3
9 Feb, 2023	SC 13G
25 Jan, 2023	8-K	CEO Change
24 Jan, 2023	4
17 Jan, 2023	8-K
9 Dec, 2022	8-K
8 Dec, 2022	8-K
8 Dec, 2022	424B5
7 Dec, 2022	8-K/A
6 Dec, 2022	424B5
2 Dec, 2022	8-K
2 Dec, 2022	DEFA14A
15 Nov, 2022	4
15 Nov, 2022	4
14 Nov, 2022	10-Q
3 Nov, 2022	8-K
3 Nov, 2022	8-K
26 Oct, 2022	DEF 14A
20 Oct, 2022	8-K
14 Oct, 2022	8-K
11 Oct, 2022	10-K
7 Oct, 2022	8-K
3 Oct, 2022	8-K
29 Sep, 2022	NT 10-K
27 Sep, 2022	8-K
21 Sep, 2022	8-K
12 Sep, 2022	4
31 Aug, 2022	4
31 Aug, 2022	4
16 Aug, 2022	8-K
8 Jul, 2022	SC 13G
6 Jul, 2022	8-K
14 Jun, 2022	DEFR14A
26 May, 2022	DEFA14A
24 May, 2022	DEF 14A
16 May, 2022	8-K
13 May, 2022	DEFA14A
13 May, 2022	8-K
13 May, 2022	DEFA14A
12 May, 2022	PRE 14A
12 May, 2022	8-K
12 May, 2022	8-K
12 May, 2022	10-Q
2 May, 2022	8-K
18 Mar, 2022	8-K
14 Mar, 2022	4
14 Mar, 2022	4
14 Feb, 2022	10-Q
14 Feb, 2022	8-K
3 Feb, 2022	SC 13G/A
1 Feb, 2022	8-K/A
1 Feb, 2022	8-K
31 Jan, 2022	8-K
26 Jan, 2022	8-K
22 Dec, 2021	DEFA14A
22 Dec, 2021	8-K
21 Dec, 2021	DEFA14A
13 Dec, 2021	4
13 Dec, 2021	4
13 Dec, 2021	4
13 Dec, 2021	4
13 Dec, 2021	4
13 Dec, 2021	4/A
13 Dec, 2021	4
13 Dec, 2021	4
13 Dec, 2021	4
10 Dec, 2021	8-K
10 Dec, 2021	DEFA14A
3 Dec, 2021	DEFA14A
30 Nov, 2021	DEFA14A
30 Nov, 2021	DEFA14A
30 Nov, 2021	DEFA14A
24 Nov, 2021	DEFA14A
17 Nov, 2021	DEFA14A
16 Nov, 2021	DEFA14A
15 Nov, 2021	10-Q
15 Nov, 2021	8-K
9 Nov, 2021	DEFA14A
9 Nov, 2021	DEFA14A
4 Nov, 2021	8-K
26 Oct, 2021	DEF 14A
26 Oct, 2021	DEFA14A
26 Oct, 2021	DEFA14A
13 Oct, 2021	PRE 14A
28 Sep, 2021	10-K
27 Sep, 2021	4
27 Sep, 2021	8-K
31 Aug, 2021	8-K
30 Aug, 2021	8-K
27 Aug, 2021	8-K
26 Aug, 2021	8-K
25 Aug, 2021	3
25 Aug, 2021	4
25 Aug, 2021	4
25 Aug, 2021	4
25 Aug, 2021	4
25 Aug, 2021	4
16 Jul, 2021	8-K
9 Jun, 2021	4
9 Jun, 2021	3
9 Jun, 2021	8-K
17 May, 2021	10-Q
17 May, 2021	8-K
6 May, 2021	8-K
4 May, 2021	4
4 May, 2021	8-K
4 Mar, 2021	3
4 Mar, 2021	4
16 Feb, 2021	10-Q
16 Feb, 2021	8-K
16 Feb, 2021	8-K
2 Feb, 2021	SC 13G
19 Jan, 2021	4
19 Jan, 2021	3
12 Jan, 2021	8-K
11 Jan, 2021	S-8
11 Jan, 2021	S-8
3 Dec, 2020	UPLOAD
3 Dec, 2020	CORRESP

Last update:2024-03-06 12:39:37.977885

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.